Inhaled steroids may increase risk of nontuberculous mycobacteria lung disease

Patients with obstructive lung disease who take inhaled corticosteroids (ICS) may be at greater risk for nontuberculous mycobacteria pulmonary disease (NTM PD), according to new research.